Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Angiomyolipoma”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableActive Not RecruitingNCT06453642
What this trial is testing

Evaluation of a Simple-Prep Controlled Embolic

Who this might be right for
EmbolizationVascular TumorRenal Angiomyolipoma+3 more
Fluidx Medical Technology, Inc. 114
Post-approval studies (Phase 4)Active Not RecruitingNCT05252585
What this trial is testing

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 4
Testing effectiveness (Phase 2)Study completedNCT00126672
What this trial is testing

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Who this might be right for
Nonmalignant NeoplasmTuberous SclerosisLymphangioleimyomatosis+1 more
Dana-Farber Cancer Institute 36
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Not applicableLooking for participantsNCT05785052
What this trial is testing

Biomarkers of Renal Cancer

Who this might be right for
Renal Cell CarcinomaTumor, SolidOncocytoma+1 more
Biorek S.R.L. 1,000
Not applicableActive Not RecruitingNCT06126159
What this trial is testing

MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers

Who this might be right for
Kidney Neoplasms
Chang Gung Memorial Hospital 44
Not applicableUnknownNCT02887781
What this trial is testing

Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France

Who this might be right for
Tuberous Sclerosis Complex
University Hospital, Brest 150
Not applicableStudy completedNCT02325505
What this trial is testing

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosisAngiomyolipoma
InCor Heart Institute 200
Not applicableUnknownNCT05617105
What this trial is testing

Molecular Characterization of Perivascular Epithelioid Cell Tumors

Who this might be right for
Perivascular Epithelioid Cell Tumor, Malignant
University Hospital, Strasbourg, France 100
Post-approval studies (Phase 4)Study completedNCT01217125
What this trial is testing

Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis

Who this might be right for
Angiomyolipoma
Fundacio Puigvert 18
Testing effectiveness (Phase 2)WithdrawnNCT01690871
What this trial is testing

A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa

Who this might be right for
Malignant PEComa (Perivascular Epithelioid Cell Tumors)
Novartis Pharmaceuticals
Not applicableStudy completedNCT03477149
What this trial is testing

EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications

Who this might be right for
VaricoceleEndoleakPortal Vein Thrombosis+2 more
Assistance Publique - Hôpitaux de Paris 50
Post-approval studies (Phase 4)Study completedNCT03525834
What this trial is testing

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT02104011
What this trial is testing

Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers

Who this might be right for
Renal AngiomyolipomasTuberous Sclerosis
University Hospital, Bordeaux 2